2015 American Transplant Congress » Concurrent Session: Liver Transplantation for Hepatocellular Carcinoma

Date: Monday, May 4, 2015

Time: 4:00pm-5:30pm

Location: Room 113-BC

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

4:00pm-4:12pm: Independent Prognostic Factors for Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: UNOS Population Study

M. Xing, H. Kim.

4:12pm-4:24pm: Refinement of Non-Invasive Diagnostic Criteria to Differentiate Tumor from Bland Portal Vein Thrombosis Before Liver Transplant in Patients With Hepatocellular Carcinoma

C. Sherman, S. Behr, J. Dodge, J. Roberts, F. Yao, N. Mehta.

4:24pm-4:36pm: The Extended Toronto Criteria for Transplantation for Hepatocellular Carcinoma. A Validation Study

G. Sapisochin, N. Goldaracena, J. Laurence, M. Dib, A. Barbas, A. Ghanekar, L. Lilly, E. Renner, M. Selzner, M. Cattral, I. McGilvray, D. Grant, P. Greig.

4:36pm-4:48pm: Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation

G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.

4:48pm-5:00pm: Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.

5:00pm-5:12pm: Multicenter Study to Develop a Novel Prediction Index for Hepatocellular Carcinoma (HCC) Recurrence After Liver Transplant (LT)

N. Mehta,¹ J. Heimbach,² D. Harnois,³ J. Dodge,¹ J. Burns,³ D. Lee,³ W. Sanchez,² J. Roberts,¹ F. Yao.¹

5:12pm-5:24pm: Adoptive Immunotherapy With Liver Allograft-Derived NK Cells Improves Recurrence-Free Survival After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma

N. Tanimine, Y. Tanaka, K. Ishiyama, M. Ohira, S. Shimizu, T. Yano, H. Ohdan.

« View all sessions from the 2015 American Transplant Congress